VolitionRx Limited

VNRX · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Revenue$627$407$246$192
% Growth54.2%65.1%28.6%
Cost of Goods Sold$0$0$0$0
Gross Profit$627$407$246$192
% Margin100%100%100%100%
R&D Expenses$2,286$2,720$2,607$2,587
G&A Expenses$3,183$3,757$3,021$3,119
SG&A Expenses$3,397$3,938$3,111$3,334
Sales & Mktg Exp.$213$181$90$215
Other Operating Expenses$46$46$50$52
Operating Expenses$5,728$6,704$5,768$5,973
Operating Income-$5,101-$6,298-$5,522-$5,781
% Margin-813.2%-1,548.6%-2,241.1%-3,016.5%
Other Income/Exp. Net-$309-$16$45-$76
Pre-Tax Income-$5,410-$6,314-$5,477-$5,857
Tax Expense$0$0$0$0
Net Income-$5,378-$6,284-$5,424-$5,793
% Margin-857.4%-1,545.2%-2,201.3%-3,022.8%
EPS-0.05-0.061-0.056-0.066
% Growth18.3%-8.9%14.8%
EPS Diluted-0.05-0.061-0.056-0.066
Weighted Avg Shares Out108,213102,65496,53686,531
Weighted Avg Shares Out Dil108,213102,65496,53686,531
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$873$449$97$92
Depreciation & Amortization$309$319$308$352
EBITDA-$4,227-$5,547-$5,072-$5,413
% Margin-673.9%-1,363.9%-2,058.4%-2,824.1%